Rubicon Research Limited (RUBICON) — Board Meeting | 14 August 2026

14 August 2026 · NSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approved merger scheme and Arinna Lifesciences acquisition

🔄 What Changed

Consolidated revenue grew to ₹5,400.21 crores and net profit to ₹847.81 crores in Q1 FY2026

💡 Investor Takeaway

The acquisitions signal expansion into new markets but may pressure short-term profitability due to integration costs.

Rubicon Research Limited announced unaudited standalone and consolidated financial results for Q1 FY2026 ending June 30, 2026, showing consolidated revenue of ₹5,400.21 crores, net profit of ₹847.81 crores, and EPS of [amount context mismatch]. The board approved the merger scheme with Kia Health Tech and an acquisition of 85% in Arinna Lifesciences for ₹1,759.17 crores, while extending IPO fund utilization to March 2027.

📄 View Original Announcement (PDF)

📊 Stock Analysis — RUBICON ✨ Ask AI About This

About Rubicon Research Limited (RUBICON)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹26,694.43 CrP/E: 90.9ROE: 22.4%ROCE: 26.6%Div Yield: 0.09%

View full RUBICON stock details →

📡 Get AI alerts when RUBICON files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RUBICON — Free

💡 Ask AI about this filing

"How will the Arinna acquisition impact profitability?""What is the expected timeline for merger approval?""How will the IPO funds be utilized by March 2027?"

Ask AI Free →

📊 More RUBICON filings

Announcement — 28 September 2026Rubicon Research Limited announced that its trading window will close on October 1, 2026, ahead of t...
🔴 Insider Trading — 29 August 2026Rubicon Research disclosed a promoter stake sale of 1.4 million shares to General Atlantic Singapore...
🔴 Insider Trading — 27 August 2026Rubicon Research Limited disclosed that General Atlantic Singapore RR Pte. Ltd., its promoter, sold ...
🟡 Board Meeting — 26 August 2026Rubicon Research Limited held its 27th Annual General Meeting on August 26, 2026, via video conferen...
🔴 Financial Results — 19 August 2026Rubicon Research reported Q1 FY27 revenue of **₹534 crores**, up **51% YoY**, with EBITDA at **₹131 ...

See all RUBICON filings →

🔥 Also filed on 14 August 2026

CEIGALLCeigall India LimitedFinancial Results MAHAPEXLTDMaha Rashtra Apex Corporation LimitedCorporate Action SAATVIKGLSaatvik Green Energy LimitedFinancial Results LIBASLibas Consumer Products LimitedCorporate Action GENUSPOWERGenus Power Infrastructures LimitedFinancial Results LUXINDLux Industries LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RUBICON files new disclosures

Track RUBICON filings, board meetings, and corporate actions. Free email alerts at 5 PM.